Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

On Feb. 29, 2008, the FDA granted tentative approval for two generic formulations of drugs used to treat HIV/AIDS. These are stavudine capsules, 15 mg, 20 mg, 30 mg, and 40 mg., and efavirenz tablets, 600 mg, all manufactured by Hetero Drugs Limited, Hyberdad, India.

FDA Notifications: Generic stavudine and efavirenz are tentatively approved by FDA